Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference

第七届癌症恶病质会议增强多样性并解决差异

基本信息

批准号：
10827795
负责人：
Teresa A Zimmers
金额：
$ 1.5万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-19 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10827795
关键词：
Address Advocacy Affect American Association of Cancer Research Anorexia Anticachexia Agent Asia Australia Award Awareness Basic Science Biological Markers Body Weight decreased Boston Brazil Cachexia Cancer Detection Caregivers Cessation of life Chronic Clinical Clinical Sciences Clinical Trials Collaborations Communication Communities Country Dedications Diagnosis Disease Disparity Distress District of Columbia Education Educational Materials Emaciation Equation Europe Event FDA approved Faculty Family Family member Fostering Goals Growth Inflammation International Intervention Joints Justice Knowledge Life Malignant Neoplasms Malignant neoplasm of liver Malignant neoplasm of pancreas Masks Medical Mentors Mentorship Muscular Atrophy National Cancer Institute North America Obesity Participant Patient Care Patient-Focused Outcomes Patients Performance Status Persons Philadelphia Physicians Postdoctoral Fellow Provider Request for Proposals Research Research Activity Research Personnel Research Support Resources Scientist Scotland Series Societies Structure Syndrome Training Translational Research Treatment Efficacy Treatment-related toxicity United Kingdom Washington advanced disease anticancer research cancer cachexia cancer therapy clinical investigation clinical translation coronavirus disease effective therapy equity, diversity, and inclusion experience forging graduate student improved outcome malignant breast neoplasm meetings muscle form outreach posters preclinical study preservation programs symposium tumor virtual

项目摘要

ABSTRACT This proposal requests partial support for the 7th Cancer Cachexia Conference organized by the Cancer Cachexia Society (CCS), to be held from September 28-30, 2023, in Edinburgh, Scotland. This iteration of the conference follows prior events in Boston, Montreal, Washington DC, Philadelphia, and two virtual versions during COVID. The long-term goal of the conference series is to foster research, awareness, and understanding of cancer cachexia among scientists, clinicians, patients, and caregivers, for the purpose of advancing identification, treatment, and cure for this major unmet medical need. Indeed, cachexia causes considerable patient and family distress and is estimated to cause some 30% of cancer deaths; yet until recently, cachexia was seldom addressed in any of the major cancer meetings. This conference series has served to help grow awareness and research around cancer cachexia and remains the only one devoted solely to this topic. Research in cancer cachexia is small relative to all cancer research and is global, with roughly equivalent research activity in North America, Europe, and Asia and notable efforts in Brazil and Australia. Hence, we have opted to hold the 7th conference in Scotland to facilitate international access and collaboration. The Aims of the 7th Cancer Cachexia Conference are to: 1 - Deliver a rich scientific program for participants while promoting networking and new collaborations. 2- Promote interaction among patients, caregivers, providers, and investigators and develop enduring patient-facing educational material. 3- Provide for training and mentorship of graduate students, postdoctoral associates, and junior faculty. 4-Expand and grow diversity, equity, and inclusion in the conference and the wider field of cancer cachexia research. The impact of this conference will be to promote progress and growth in the clinical investigation of anti-cachexia therapies and to strengthen knowledge, research, and research capacity in cancer cachexia.

抽象的该提案请求部分支持癌症协会组织的第七届癌症恶病质会议恶病质协会 (CCS) 将于 2023 年 9 月 28 日至 30 日在苏格兰爱丁堡举行。本次迭代的会议之前在波士顿、蒙特利尔、华盛顿特区、费城举行，并有两个虚拟版本新冠疫情期间。该系列会议的长期目标是促进研究、意识和理解科学家、临床医生、患者和护理人员对癌症恶病质的认识，以推进识别、治疗和治愈这一未满足的重大医疗需求。事实上，恶病质会导致相当大的患者和家人的痛苦估计导致约 30% 的癌症死亡；但直到最近，恶病质在任何主要的癌症会议上都很少讨论这个问题。该会议系列有助于帮助成长关于癌症恶病质的认识和研究，仍然是唯一专门致力于这一主题的机构。研究癌症恶病质相对于所有癌症研究而言规模较小，并且是全球性的，研究活动大致相当在北美、欧洲和亚洲，巴西和澳大利亚的努力值得关注。因此，我们选择保留在苏格兰举行的第七次会议，旨在促进国际交流和合作。第七种癌症的目标 Cachexia 会议旨在： 1 - 为参与者提供丰富的科学计划，同时促进网络和新的合作。 2- 促进患者、护理人员、提供者和研究者之间的互动，并制定持久的面向患者的教育材料。 3- 为研究生提供培训和指导，博士后研究员和初级教师。 4-扩大和提高会议的多样性、公平性和包容性以及更广泛的癌症恶病质研究领域。这次会议的影响将是促进进步和抗恶病质疗法的临床研究不断增长，并加强知识、研究和癌症恶病质的研究能力。